$THMO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ThermoGenesis Holdings, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ThermoGenesis Holdings, Inc.. Get notifications about new insider transactions in ThermoGenesis Holdings, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 08 2020 | THMO | ThermoGenesis Hold ... | Cauble Jeffery | Chief Financial Off ... | Option Exercise | A | 5.94 | 40,000 | 237,600 | 40,000 | |
Jun 08 2020 | THMO | ThermoGenesis Hold ... | Xu Xiaochun | CEO | Option Exercise | A | 5.94 | 240,000 | 1,425,600 | 240,000 | |
Jun 08 2020 | THMO | ThermoGenesis Hold ... | Donaghy Debra | Director | Option Exercise | A | 5.94 | 10,000 | 59,400 | 10,000 | |
Jun 08 2020 | THMO | ThermoGenesis Hold ... | Westgate Mark | Director | Option Exercise | A | 5.94 | 10,000 | 59,400 | 10,000 | |
Jun 08 2020 | THMO | ThermoGenesis Hold ... | JOSEPH THOMIS | Director | Option Exercise | A | 5.94 | 10,000 | 59,400 | 10,000 | |
Jun 08 2020 | THMO | ThermoGenesis Hold ... | MEDFORD RUSSELL M | Director | Option Exercise | A | 5.94 | 10,000 | 59,400 | 10,000 | |
Apr 30 2020 | THMO | ThermoGenesis Hold ... | Xu Xiaochun | CEO | Sell | J | 1.80 | 621,637 | 1,118,947 | 1,728,857 | 2.4 M to 1.7 M (-26.45 %) |
Feb 18 2020 | KOOL | ThermoGenesis Hold ... | Xu Xiaochun | CEO | Buy | C | 1.80 | 1,666,670 | 3,000,006 | 2,350,494 | 683.8 K to 2.4 M (+243.73 %) |
Jan 03 2020 | KOOL | ThermoGenesis Hold ... | Xu Xiaochun | CEO | Option Exercise | P | 80.00 | 352,942 | 28,235,360 | 352,942 | |
Jan 03 2020 | KOOL | ThermoGenesis Hold ... | Xu Xiaochun | CEO | Option Exercise | P | 80.00 | 352,942 | 28,235,360 | 0 | |
Jan 03 2020 | KOOL | ThermoGenesis Hold ... | Xu Xiaochun | CEO | Buy | P | 2,277,130.00 | 683,824 | 1,557,158,880,416 | 683,824 | 0 to 683.8 K |
Jan 03 2020 | KOOL | ThermoGenesis Hold ... | Xu Xiaochun | CEO | Sell | P | 2,277,130.00 | 683,824 | 1,557,158,880,416 | 0 | 683.8 K to 0 (-100.00 %) |
Sep 18 2019 | KOOL | CESCA THERAPEUTICS ... | JOSEPH THOMIS | Director | Option Exercise | A | 4.38 | 3,400 | 14,892 | 3,400 | |
Sep 18 2019 | KOOL | CESCA THERAPEUTICS ... | Westgate Mark | Director | Option Exercise | A | 4.38 | 3,400 | 14,892 | 3,400 | |
Sep 18 2019 | KOOL | CESCA THERAPEUTICS ... | MEDFORD RUSSELL M | Director | Option Exercise | A | 4.38 | 3,400 | 14,892 | 3,400 | |
Dec 18 2018 | KOOL | CESCA THERAPEUTICS ... | Cauble Jeffery | Principal Accountin ... | Option Exercise | A | 0.30 | 160,000 | 47,664 | 160,000 | |
Dec 18 2018 | KOOL | CESCA THERAPEUTICS ... | Cauble Jeffery | Principal Accountin ... | Option Exercise | A | 0.30 | 40,000 | 11,916 | 40,000 | |
Dec 18 2018 | KOOL | CESCA THERAPEUTICS ... | Xu Xiaochun | CEO | Option Exercise | A | 0.30 | 640,000 | 190,656 | 640,000 | |
Dec 18 2018 | KOOL | CESCA THERAPEUTICS ... | Xu Xiaochun | CEO | Option Exercise | A | 0.30 | 160,000 | 47,664 | 160,000 | |
Sep 05 2018 | KOOL | CESCA THERAPEUTICS ... | JOSEPH THOMIS | Director | Sell | J | 0.00 | 35,000 | 0 | 0 | 35 K to 0 (-100.00 %) |
Sep 05 2018 | KOOL | CESCA THERAPEUTICS ... | JOSEPH THOMIS | Director | Sell | J | 0.00 | 35,000 | 0 | 0 | 35 K to 0 (-100.00 %) |
Aug 30 2018 | KOOL | CESCA THERAPEUTICS ... | JOSEPH THOMIS | Director | Buy | P | 0.18 | 35,000 | 6,300 | 35,000 | 0 to 35 K |
Jun 26 2018 | KOOL | CESCA THERAPEUTICS ... | Xu James | Sr. VP, Legal Affai ... | Option Exercise | A | 0.44 | 13,500 | 5,900 | 13,500 | |
Apr 18 2018 | KOOL | CESCA THERAPEUTICS ... | Xu James | Director | Option Exercise | D | 3.00 | 34,000 | 102,000 | 20,000 | |
Apr 18 2018 | KOOL | CESCA THERAPEUTICS ... | MEDFORD RUSSELL M | Director | Option Exercise | D | 3.00 | 34,000 | 102,000 | 20,000 | |
Apr 18 2018 | KOOL | CESCA THERAPEUTICS ... | JOSEPH THOMIS | Director | Option Exercise | D | 3.00 | 34,000 | 102,000 | 20,000 | |
Apr 18 2018 | KOOL | CESCA THERAPEUTICS ... | Westgate Mark | Director | Option Exercise | D | 3.00 | 34,000 | 102,000 | 20,000 | |
Mar 13 2018 | KOOL | CESCA THERAPEUTICS ... | JOSEPH THOMIS | Director | Option Exercise | A | 3.00 | 54,000 | 162,000 | 54,000 | |
Mar 13 2018 | KOOL | CESCA THERAPEUTICS ... | Westgate Mark | Director | Option Exercise | A | 3.00 | 54,000 | 162,000 | 54,000 | |
Mar 13 2018 | KOOL | CESCA THERAPEUTICS ... | Xu James | Director | Option Exercise | A | 3.00 | 54,000 | 162,000 | 54,000 | |
Mar 13 2018 | KOOL | CESCA THERAPEUTICS ... | MEDFORD RUSSELL M | Director | Option Exercise | A | 3.00 | 54,000 | 162,000 | 54,000 | |
Jan 03 2018 | KOOL | CESCA THERAPEUTICS ... | LIU VIVIAN H | COO | Option Exercise | A | 3.00 | 250,000 | 750,000 | 250,000 | |
Jul 03 2017 | KOOL | CESCA THERAPEUTICS ... | Cauble Jeffery | Principal Accountin ... | Grant | A | 3.17 | 4,080 | 12,934 | 5,240 | 9.3 K to 5.2 K (-43.78 %) |
Jul 03 2017 | KOOL | CESCA THERAPEUTICS ... | Cauble Jeffery | Principal Accountin ... | Grant | A | 3.17 | 9,320 | 29,544 | 9,320 | 0 to 9.3 K |
May 16 2017 | KOOL | CESCA THERAPEUTICS ... | Westgate Mark | Director | Option Exercise | A | 3.19 | 13,500 | 43,065 | 13,500 | |
May 12 2017 | KOOL | CESCA THERAPEUTICS ... | Rao Mahendra S. | Director | Option Exercise | A | 3.19 | 13,500 | 43,065 | 13,500 | |
May 12 2017 | KOOL | CESCA THERAPEUTICS ... | JOSEPH THOMIS | Director | Option Exercise | A | 3.19 | 12,250 | 39,078 | 12,250 | |
May 12 2017 | KOOL | CESCA THERAPEUTICS ... | Xu James | Director | Option Exercise | A | 3.19 | 13,500 | 43,065 | 13,500 | |
Mar 30 2017 | KOOL | CESCA THERAPEUTICS ... | Ellner Kimberly Kay | VP, Manufacturing | Grant | A | 3.15 | 2,338 | 7,365 | 1,699 | 4 K to 1.7 K (-57.91 %) |
Mar 30 2017 | KOOL | CESCA THERAPEUTICS ... | Ellner Kimberly Kay | VP, Manufacturing | Grant | A | 3.15 | 162 | 510 | 4,037 | 4.2 K to 4 K (-3.86 %) |
Feb 28 2017 | KOOL | CESCA THERAPEUTICS ... | LIU VIVIAN H | COO | Option Exercise | A | 2.89 | 25,000 | 72,250 | 25,000 | |
Feb 28 2017 | KOOL | CESCA THERAPEUTICS ... | LIU VIVIAN H | COO | Grant | A | 2.89 | 25,000 | 72,250 | 25,000 | 0 to 25 K |
Dec 28 2016 | KOOL | CESCA THERAPEUTICS ... | Boyalife (Hong Kong) Ltd | 10% Owner | Option Exercise | P | 0.40 | 2,941,177 | 1,176,471 | 3,529,413 | |
Dec 28 2016 | KOOL | CESCA THERAPEUTICS ... | Boyalife (Hong Kong) Ltd | 10% Owner | Buy | P | 2.52 | 6,102,942 | 15,379,414 | 6,838,237 | 735.3 K to 6.8 M (+830.00 %) |
Dec 20 2016 | KOOL | CESCA THERAPEUTICS ... | Xu Xiaochun | Interim CEO | Option Exercise | A | 2.91 | 50,000 | 145,500 | 50,000 | |
Sep 30 2016 | KOOL | CESCA THERAPEUTICS ... | Ellner Kimberly Kay | VP, Manufacturing | Grant | A | 4.00 | 3,000 | 12,000 | 4,199 | 7.2 K to 4.2 K (-41.67 %) |
Sep 30 2016 | KOOL | CESCA THERAPEUTICS ... | Ellner Kimberly Kay | VP, Manufacturing | Grant | A | 3.98 | 502 | 1,998 | 7,199 | 7.7 K to 7.2 K (-6.52 %) |
Aug 24 2016 | KOOL | CESCA THERAPEUTICS ... | Xu Xiaochun | Director | Grant | A | 3.40 | 6,102,941 | 20,749,999 | 6,838,236 | 735.3 K to 6.8 M (+830.00 %) |
Jul 28 2016 | KOOL | CESCA THERAPEUTICS ... | Ellner Kimberly Kay | VP, Manufacturing | Grant | A | 0.00 | 12,997 | 0 | 20,818 | 7.8 K to 20.8 K (+166.18 %) |
Jul 28 2016 | KOOL | CESCA THERAPEUTICS ... | STRACEY ROBIN C | CEO | Grant | A | 0.00 | 29,720 | 0 | 116,676 | 87 K to 116.7 K (+34.18 %) |
Jul 28 2016 | KOOL | CESCA THERAPEUTICS ... | BRUCH MICHAEL | CFO | Grant | A | 0.00 | 15,734 | 0 | 30,688 | 15 K to 30.7 K (+105.22 %) |
Jul 13 2016 | KOOL | CESCA THERAPEUTICS ... | Xu Xiaochun | Director | Option Exercise | A | 2.86 | 1,250 | 3,575 | 1,250 | |
Jul 13 2016 | KOOL | CESCA THERAPEUTICS ... | Xu Xiaochun | Director | Option Exercise | A | 2.86 | 1,250 | 3,575 | 1,250 | |
Jul 11 2016 | KOOL | CESCA THERAPEUTICS ... | STRACEY ROBIN C | CEO | Option Exercise | A | 2.86 | 60,000 | 171,600 | 60,000 | |
Jul 11 2016 | KOOL | CESCA THERAPEUTICS ... | STRACEY ROBIN C | CEO | Payment of Exercise | F | 2.86 | 20,732 | 59,294 | 39,956 | 60.7 K to 40 K (-34.16 %) |
Jul 11 2016 | KOOL | CESCA THERAPEUTICS ... | STRACEY ROBIN C | CEO | Grant | A | 2.86 | 55,168 | 157,780 | 57,688 | 2.5 K to 57.7 K (+2,189.21 %) |
Jul 11 2016 | KOOL | CESCA THERAPEUTICS ... | BRUCH MICHAEL | CFO | Option Exercise | A | 2.86 | 16,000 | 45,760 | 16,000 | |
Jul 11 2016 | KOOL | CESCA THERAPEUTICS ... | BRUCH MICHAEL | CFO | Payment of Exercise | F | 2.86 | 5,390 | 15,415 | 14,775 | 20.2 K to 14.8 K (-26.73 %) |
Jul 11 2016 | KOOL | CESCA THERAPEUTICS ... | BRUCH MICHAEL | CFO | Grant | A | 2.86 | 14,603 | 41,765 | 20,165 | 5.6 K to 20.2 K (+262.55 %) |
Jul 11 2016 | KOOL | CESCA THERAPEUTICS ... | Ellner Kimberly Kay | VP, Manufacturing | Option Exercise | A | 2.86 | 16,000 | 45,760 | 16,000 | |
Jul 11 2016 | KOOL | CESCA THERAPEUTICS ... | Ellner Kimberly Kay | VP, Manufacturing | Payment of Exercise | F | 2.86 | 5,078 | 14,523 | 7,701 | 12.8 K to 7.7 K (-39.74 %) |
Jul 11 2016 | KOOL | CESCA THERAPEUTICS ... | Ellner Kimberly Kay | VP, Manufacturing | Grant | A | 2.86 | 12,062 | 34,497 | 12,779 | 717 to 12.8 K (+1,682.29 %) |
Jul 06 2016 | KOOL | CESCA THERAPEUTICS ... | Rhein Denis Michael | Director | Option Exercise | A | 2.86 | 1,250 | 3,575 | 3,750 | |
Jul 06 2016 | KOOL | CESCA THERAPEUTICS ... | Rhein Denis Michael | Director | Option Exercise | A | 2.86 | 1,250 | 3,575 | 3,750 | |
Jul 06 2016 | KOOL | CESCA THERAPEUTICS ... | Rhein Denis Michael | Director | Grant | A | 2.86 | 1,278 | 3,655 | 28,499 | 27.2 K to 28.5 K (+4.69 %) |
Jul 06 2016 | KOOL | CESCA THERAPEUTICS ... | Rhein Denis Michael | Director | Grant | A | 2.86 | 1,278 | 3,655 | 28,499 | 27.2 K to 28.5 K (+4.69 %) |
Jul 06 2016 | KOOL | CESCA THERAPEUTICS ... | MOORE CRAIG W | Director | Option Exercise | A | 2.86 | 1,250 | 3,575 | 4,500 | |
Jul 06 2016 | KOOL | CESCA THERAPEUTICS ... | MOORE CRAIG W | Director | Grant | A | 2.86 | 1,737 | 4,968 | 7,788 | 6.1 K to 7.8 K (+28.71 %) |
Jul 06 2016 | KOOL | CESCA THERAPEUTICS ... | Rao Mahendra S. | Director | Option Exercise | A | 2.86 | 1,250 | 3,575 | 5,000 | |
Jul 06 2016 | KOOL | CESCA THERAPEUTICS ... | Rao Mahendra S. | Director | Grant | A | 2.86 | 2,448 | 7,001 | 5,255 | 2.8 K to 5.3 K (+87.21 %) |
Jul 05 2016 | KOOL | CESCA THERAPEUTICS ... | Bagnall Mark | Director | Option Exercise | A | 2.86 | 1,250 | 3,575 | 1,250 | |
Apr 05 2016 | KOOL | CESCA THERAPEUTICS ... | Rhein Denis Michael | Director | Grant | A | 4.01 | 912 | 3,657 | 27,221 | 26.3 K to 27.2 K (+3.47 %) |
Apr 05 2016 | KOOL | CESCA THERAPEUTICS ... | MOORE CRAIG W | Director | Grant | A | 4.01 | 1,239 | 4,968 | 6,051 | 4.8 K to 6.1 K (+25.75 %) |
Apr 05 2016 | KOOL | CESCA THERAPEUTICS ... | Rao Mahendra S. | Director | Grant | A | 4.01 | 1,746 | 7,001 | 2,807 | 1.1 K to 2.8 K (+164.56 %) |
Mar 18 2016 | KOOL | CESCA THERAPEUTICS ... | Xu Xiaochun | Director | Option Exercise | A | 4.20 | 1,250 | 5,250 | 1,250 | |
Mar 17 2016 | KOOL | CESCA THERAPEUTICS ... | Ellner Kimberly Kay | VP, Manufacturing | Option Exercise | A | 4.20 | 3,750 | 15,750 | 4,500 | |
Nov 10 2015 | KOOL | CESCA THERAPEUTICS ... | Harris Kenneth | 10% Owner | Sell | S | 0.60 | 2,200 | 1,320 | 4,490,410 | 4.5 M to 4.5 M (-0.05 %) |
Nov 10 2015 | KOOL | CESCA THERAPEUTICS ... | Harris Kenneth | 10% Owner | Sell | S | 0.60 | 48,468 | 29,081 | 4,492,610 | 4.5 M to 4.5 M (-1.07 %) |
Nov 10 2015 | KOOL | CESCA THERAPEUTICS ... | Harris Kenneth | 10% Owner | Sell | S | 0.60 | 30,190 | 18,114 | 4,541,078 | 4.6 M to 4.5 M (-0.66 %) |
Nov 04 2015 | KOOL | CESCA THERAPEUTICS ... | Harris Kenneth | 10% Owner | Sell | S | 0.60 | 4,810 | 2,886 | 4,571,268 | 4.6 M to 4.6 M (-0.11 %) |
Nov 04 2015 | KOOL | CESCA THERAPEUTICS ... | Harris Kenneth | 10% Owner | Sell | S | 0.60 | 5,700 | 3,420 | 4,576,078 | 4.6 M to 4.6 M (-0.12 %) |
Nov 02 2015 | KOOL | CESCA THERAPEUTICS ... | Harris Kenneth | 10% Owner | Sell | S | 0.60 | 8,632 | 5,179 | 4,581,778 | 4.6 M to 4.6 M (-0.19 %) |
Oct 26 2015 | KOOL | CESCA THERAPEUTICS ... | BRUCH MICHAEL | CFO | Option Exercise | A | 0.60 | 50,000 | 30,000 | 100,000 | |
Oct 09 2015 | KOOL | CESCA THERAPEUTICS ... | Rao Mahendra S. | Director | Grant | A | 0.53 | 7,075 | 3,750 | 21,209 | 14.1 K to 21.2 K (+50.06 %) |
Oct 09 2015 | KOOL | CESCA THERAPEUTICS ... | MOORE CRAIG W | Director | Grant | A | 0.53 | 9,375 | 4,969 | 96,223 | 86.8 K to 96.2 K (+10.79 %) |
Sep 30 2015 | KOOL | CESCA THERAPEUTICS ... | Harris Kenneth | 10% Owner | Option Exercise | A | 0.60 | 270,000 | 162,000 | 530,000 | |
Sep 22 2015 | KOOL | CESCA THERAPEUTICS ... | BRUCH MICHAEL | Interim CFO | Payment of Exercise | F | 0.65 | 9,915 | 6,395 | 114,827 | 124.7 K to 114.8 K (-7.95 %) |
Sep 14 2015 | KOOL | CESCA THERAPEUTICS ... | BRUCH MICHAEL | Interim CFO | Option Exercise | A | 0.63 | 50,000 | 31,500 | 50,000 | |
Sep 14 2015 | KOOL | CESCA THERAPEUTICS ... | BRUCH MICHAEL | Interim CFO | Grant | A | 0.63 | 20,000 | 12,600 | 124,742 | 104.7 K to 124.7 K (+19.09 %) |
Sep 04 2015 | KOOL | CESCA THERAPEUTICS ... | Plavan Matthew T | Former CEO | Sell | S | 0.69 | 5,871 | 4,036 | 245,066 | 250.9 K to 245.1 K (-2.34 %) |
Sep 04 2015 | KOOL | CESCA THERAPEUTICS ... | Plavan Matthew T | Former CEO | Sell | S | 0.68 | 11,400 | 7,752 | 250,937 | 262.3 K to 250.9 K (-4.35 %) |
Jul 02 2015 | KOOL | CESCA THERAPEUTICS ... | Rhein Denis Michael | Director | Option Exercise | A | 0.81 | 25,000 | 20,248 | 50,000 | |
Jul 02 2015 | KOOL | CESCA THERAPEUTICS ... | MOORE CRAIG W | Director | Option Exercise | A | 0.81 | 25,000 | 20,248 | 80,000 | |
Jul 02 2015 | KOOL | CESCA THERAPEUTICS ... | MOORE CRAIG W | Director | Grant | A | 0.85 | 5,846 | 4,969 | 86,848 | 81 K to 86.8 K (+7.22 %) |
Jul 02 2015 | KOOL | CESCA THERAPEUTICS ... | Rao Mahendra S. | Director | Option Exercise | A | 0.81 | 25,000 | 20,248 | 90,000 | |
Jul 02 2015 | KOOL | CESCA THERAPEUTICS ... | Rao Mahendra S. | Director | Grant | A | 0.85 | 4,412 | 3,750 | 14,134 | 9.7 K to 14.1 K (+45.38 %) |
Jun 11 2015 | KOOL | CESCA THERAPEUTICS ... | STRACEY ROBIN C | CEO | Option Exercise | A | 0.83 | 1,000,000 | 832,000 | 1,065,000 | |
Jun 11 2015 | KOOL | CESCA THERAPEUTICS ... | STRACEY ROBIN C | CEO | Grant | A | 0.83 | 1,000,000 | 832,000 | 1,050,405 | 50.4 K to 1.1 M (+1,983.93 %) |
Apr 02 2015 | KOOL | CESCA THERAPEUTICS ... | MOORE CRAIG W | Director | Grant | A | 0.90 | 5,799 | 5,219 | 81,002 | 75.2 K to 81 K (+7.71 %) |
Apr 02 2015 | KOOL | CESCA THERAPEUTICS ... | Rao Mahendra S. | Director | Grant | A | 0.90 | 9,722 | 8,750 | 9,722 | 0 to 9.7 K |
Mar 23 2015 | KOOL | CESCA THERAPEUTICS ... | Pappa Kenneth | VP, Manufacturing, ... | Payment of Exercise | F | 0.90 | 5,019 | 4,517 | 81,556 | 86.6 K to 81.6 K (-5.80 %) |
Feb 20 2015 | KOOL | CESCA THERAPEUTICS ... | Sivilotti Mitchel | 10% Owner | Payment of Exercise | F | 0.88 | 6,692 | 5,889 | 4,660,539 | 4.7 M to 4.7 M (-0.14 %) |
Feb 20 2015 | KOOL | CESCA THERAPEUTICS ... | Harris Kenneth | President | Payment of Exercise | F | 0.88 | 6,692 | 5,889 | 4,590,410 | 4.6 M to 4.6 M (-0.15 %) |
Jan 05 2015 | KOOL | CESCA THERAPEUTICS ... | MOORE CRAIG W | Director | Grant | A | 1.02 | 5,116 | 5,218 | 75,203 | 70.1 K to 75.2 K (+7.30 %) |
Dec 09 2014 | KOOL | CESCA THERAPEUTICS ... | Plavan Matthew T | Director | Payment of Exercise | F | 1.05 | 23,765 | 24,953 | 262,337 | 286.1 K to 262.3 K (-8.31 %) |
Dec 03 2014 | KOOL | CESCA THERAPEUTICS ... | BESSEY DAN T | CFO | Option Exercise | A | 1.02 | 150,000 | 153,000 | 393,585 | |
Oct 02 2014 | KOOL | CESCA THERAPEUTICS ... | MOORE CRAIG W | Director | Grant | A | 1.22 | 8,555 | 10,437 | 70,087 | 61.5 K to 70.1 K (+13.90 %) |
Oct 02 2014 | KOOL | CESCA THERAPEUTICS ... | STRACEY ROBIN C | Director | Grant | A | 1.22 | 5,738 | 7,000 | 50,405 | 44.7 K to 50.4 K (+12.85 %) |
Aug 29 2014 | KOOL | CESCA THERAPEUTICS ... | Harris Kenneth | President | Option Exercise | A | 1.31 | 160,000 | 209,600 | 260,000 | |
Aug 21 2014 | KOOL | CESCA THERAPEUTICS ... | Sivilotti Mitchel | 10% Owner | Option Exercise | A | 1.31 | 80,000 | 104,800 | 180,000 | |
Aug 21 2014 | KOOL | CESCA THERAPEUTICS ... | BESSEY DAN T | CFO | Option Exercise | A | 1.31 | 160,000 | 209,600 | 243,585 | |
Aug 21 2014 | KOOL | CESCA THERAPEUTICS ... | Plavan Matthew T | CEO & Director | Option Exercise | A | 1.31 | 400,000 | 524,000 | 762,500 | |
Aug 21 2014 | KOOL | CESCA THERAPEUTICS ... | Pappa Kenneth | VP, Manufacturing, ... | Option Exercise | A | 1.31 | 80,000 | 104,800 | 136,200 | |
Jul 31 2014 | KOOL | CESCA THERAPEUTICS ... | Pappa Kenneth | VP, Mfg, Eng and IT | Payment of Exercise | F | 1.39 | 5,508 | 7,656 | 86,575 | 92.1 K to 86.6 K (-5.98 %) |
Jul 31 2014 | KOOL | CESCA THERAPEUTICS ... | Plavan Matthew T | CEO & Director | Payment of Exercise | F | 1.39 | 8,488 | 11,798 | 293,602 | 302.1 K to 293.6 K (-2.81 %) |
Jul 02 2014 | KOOL | CESCA THERAPEUTICS ... | Rao Mahendra S. | Director | Option Exercise | A | 1.38 | 25,000 | 34,500 | 50,000 | |
Jul 02 2014 | KOOL | CESCA THERAPEUTICS ... | STRACEY ROBIN C | Director | Option Exercise | A | 1.38 | 25,000 | 34,500 | 65,000 | |
Jul 02 2014 | KOOL | CESCA THERAPEUTICS ... | STRACEY ROBIN C | Director | Grant | A | 1.39 | 5,036 | 7,000 | 44,667 | 39.6 K to 44.7 K (+12.71 %) |
Jul 02 2014 | KOOL | CESCA THERAPEUTICS ... | MCENANY PATRICK J | Director | Option Exercise | A | 1.38 | 25,000 | 34,500 | 122,750 | |
Jul 02 2014 | KOOL | CESCA THERAPEUTICS ... | MOORE CRAIG W | Director | Option Exercise | A | 1.38 | 25,000 | 34,500 | 95,000 | |
Jul 02 2014 | KOOL | CESCA THERAPEUTICS ... | MOORE CRAIG W | Director | Grant | A | 1.39 | 7,509 | 10,438 | 61,532 | 54 K to 61.5 K (+13.90 %) |
Apr 03 2014 | KOOL | CESCA THERAPEUTICS ... | STRACEY ROBIN C | Director | Grant | A | 1.70 | 6,471 | 11,001 | 39,631 | 33.2 K to 39.6 K (+19.51 %) |
Apr 03 2014 | KOOL | CESCA THERAPEUTICS ... | MOORE CRAIG W | Director | Grant | A | 1.70 | 6,140 | 10,438 | 54,023 | 47.9 K to 54 K (+12.82 %) |
Jan 03 2014 | KOOL | CESCA THERAPEUTICS ... | MOORE CRAIG W | Director | Grant | A | 1.02 | 5,393 | 5,500 | 47,883 | 42.5 K to 47.9 K (+12.69 %) |
Jan 03 2014 | KOOL | CESCA THERAPEUTICS ... | STRACEY ROBIN C | Director | Grant | A | 1.02 | 9,070 | 9,250 | 33,160 | 24.1 K to 33.2 K (+37.65 %) |
Mar 05 2014 | KOOL | CESCA THERAPEUTICS ... | Plavan Matthew T | CEO & Director | Option Exercise | A | 2.18 | 100,000 | 218,000 | 362,500 | |
Mar 05 2014 | KOOL | CESCA THERAPEUTICS ... | Plavan Matthew T | CEO & Director | Grant | A | 0.00 | 210,000 | 0 | 305,485 | 95.5 K to 305.5 K (+219.93 %) |
Mar 05 2014 | KOOL | CESCA THERAPEUTICS ... | BESSEY DAN T | CFO | Option Exercise | A | 2.18 | 33,585 | 73,215 | 83,585 | |
Mar 05 2014 | KOOL | CESCA THERAPEUTICS ... | BESSEY DAN T | CFO | Grant | A | 0.00 | 67,500 | 0 | 117,500 | 50 K to 117.5 K (+135.00 %) |
Mar 05 2014 | KOOL | CESCA THERAPEUTICS ... | BAKER HAROLD | VP Commercial Opera ... | Option Exercise | A | 2.18 | 18,700 | 40,766 | 93,700 | |
Mar 05 2014 | KOOL | CESCA THERAPEUTICS ... | BAKER HAROLD | VP Commercial Opera ... | Grant | A | 0.00 | 37,500 | 0 | 76,867 | 39.4 K to 76.9 K (+95.26 %) |
Mar 05 2014 | KOOL | CESCA THERAPEUTICS ... | Pappa Kenneth | VP, Manufacturing, ... | Option Exercise | A | 2.18 | 18,700 | 40,766 | 56,200 | |
Mar 05 2014 | KOOL | CESCA THERAPEUTICS ... | Pappa Kenneth | VP, Manufacturing, ... | Grant | A | 0.00 | 37,500 | 0 | 92,084 | 54.6 K to 92.1 K (+68.70 %) |
Oct 02 2013 | KOOL | CESCA THERAPEUTICS ... | STRACEY ROBIN C | Director | Grant | A | 1.08 | 7,870 | 8,500 | 24,090 | 16.2 K to 24.1 K (+48.52 %) |
Oct 02 2013 | KOOL | CESCA THERAPEUTICS ... | MOORE CRAIG W | Director | Grant | A | 1.08 | 5,093 | 5,500 | 42,490 | 37.4 K to 42.5 K (+13.62 %) |
Jul 02 2013 | KOOL | CESCA THERAPEUTICS ... | STRACEY ROBIN C | Director | Option Exercise | A | 1.37 | 15,000 | 20,550 | 40,000 | |
Jul 02 2013 | KOOL | CESCA THERAPEUTICS ... | STRACEY ROBIN C | Director | Grant | A | 1.35 | 10,926 | 14,750 | 16,220 | 5.3 K to 16.2 K (+206.38 %) |
Jul 02 2013 | KOOL | CESCA THERAPEUTICS ... | MCENANY PATRICK J | Director | Option Exercise | A | 1.37 | 15,000 | 20,550 | 109,000 | |
Jul 02 2013 | KOOL | CESCA THERAPEUTICS ... | MOORE CRAIG W | Director | Option Exercise | A | 1.37 | 15,000 | 20,550 | 76,250 | |
Jul 02 2013 | KOOL | CESCA THERAPEUTICS ... | MOORE CRAIG W | Director | Grant | A | 1.35 | 5,926 | 8,000 | 37,397 | 31.5 K to 37.4 K (+18.83 %) |
Apr 04 2013 | KOOL | CESCA THERAPEUTICS ... | STRACEY ROBIN C | Director | Grant | A | 0.85 | 5,294 | 4,500 | 5,294 | 0 to 5.3 K |
Apr 04 2013 | KOOL | CESCA THERAPEUTICS ... | MOORE CRAIG W | Director | Grant | A | 0.85 | 6,471 | 5,500 | 31,471 | 25 K to 31.5 K (+25.88 %) |
Aug 01 2012 | KOOL | CESCA THERAPEUTICS ... | Plavan Matthew T | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 0.93 | 162,500 | 150,313 | 325,000 | |
Jul 05 2012 | KOOL | CESCA THERAPEUTICS ... | MCENANY PATRICK J | Director | Option Exercise | A | 0.90 | 15,000 | 13,500 | 100,500 | |
Jul 05 2012 | KOOL | CESCA THERAPEUTICS ... | MOORE CRAIG W | Director | Option Exercise | A | 0.90 | 15,000 | 13,500 | 61,250 | |
Jul 05 2012 | KOOL | CESCA THERAPEUTICS ... | CARTER DAVID WARREN | Director | Option Exercise | A | 0.90 | 15,000 | 13,500 | 61,250 | |
Jan 31 2012 | KOOL | CESCA THERAPEUTICS ... | MOORE CRAIG W | Director | Grant | A | 1.02 | 25,000 | 25,500 | 25,000 | 0 to 25 K |
Nov 01 2011 | KOOL | CESCA THERAPEUTICS ... | HARGREAVES KAREN AUDITORE | VP, Scientific Affa ... | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Aug 02 2011 | KOOL | CESCA THERAPEUTICS ... | Plavan Matthew T | CFO & EVP Business ... | Grant | A | 0.00 | 75,000 | 0 | 118,750 | 43.8 K to 118.8 K (+171.43 %) |
Aug 02 2011 | KOOL | CESCA THERAPEUTICS ... | ENGLE J MELVILLE | Chairman & CEO | Grant | A | 0.00 | 100,000 | 0 | 172,500 | 72.5 K to 172.5 K (+137.93 %) |